CDC

September 29, 2023

Vanderbilt Kennedy Center to begin estimating prevalence of cerebral palsy in Middle Tennessee

Vanderbilt Kennedy Center’s Treatment and Research Institute for Autism Spectrum Disorders has received funding to monitor and estimate prevalence of cerebral palsy (CP) in Middle Tennessee.

April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.

February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
January 26, 2023

Vaccine effectiveness research continues to grow

Vanderbilt’s participation in vaccine effectiveness research continues to grow, with the Medical Center playing critical roles in several networks focused on surveillance of vaccine-preventable respiratory diseases.

January 26, 2023

Study to explore COVID’s impact on essential workers

Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.

January 19, 2023

Emerging Infections Program lands national award for COVID response

Vanderbilt’s Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.